Ocular Therapeutix (OCUL) Tops Q4 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $13.42 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue